APA (7th ed.) Citation

Hansen, A. H., Andersen, K. I. H., Xin, L., Krigslund, O., Behrendt, N., Engelholm, L. H., . . . Qvortrup, K. (2025). A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models. Molecules, 30(2), 391. https://doi.org/10.3390/molecules30020391

Chicago Style (17th ed.) Citation

Hansen, Anders H., Kasper I. H. Andersen, Li Xin, Oliver Krigslund, Niels Behrendt, Lars H. Engelholm, Claus H. Bang-Bertelsen, Sanne Schoffelen, and Katrine Qvortrup. "A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models." Molecules 30, no. 2 (2025): 391. https://doi.org/10.3390/molecules30020391.

MLA (9th ed.) Citation

Hansen, Anders H., et al. "A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models." Molecules, vol. 30, no. 2, 2025, p. 391, https://doi.org/10.3390/molecules30020391.